WALLETTE WIDENER: Open Payments
NPI 1669580262 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,043 in 86 payments from 23 companies in 2025. Trend: 2023 $2,923 · 2024 $2,862 · 2025 $2,043
Food & beverage: $2,043
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $494 |
| Amgen Inc. | 7 | $270 |
| Alexion Pharmaceuticals, Inc. | 2 | $174 |
| EMD Serono, Inc. | 4 | $170 |
| Novartis Pharmaceuticals Corporation | 9 | $153 |
| TG Therapeutics, Inc. | 6 | $135 |
| UCB, Inc. | 4 | $91 |
| Biogen, Inc. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Merz Pharmaceuticals, LLC | 2 | $45 |
Products named: UPLIZNA, BOTOX, ULTOMIRIS, KESIMPTA, UBRELVY, BRIUMVI, QULIPTA, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
